**Core Concept**
Alzheimer's disease is a neurodegenerative disorder characterized by progressive cognitive decline, with cholinergic dysfunction playing a significant role in its pathophysiology. Treatment strategies focus on enhancing cholinergic transmission or modulating other neurotransmitter systems to alleviate symptoms.

**Why the Correct Answer is Right**
Biperiden is an anticholinergic medication primarily used to treat Parkinson's disease and extrapyramidal side effects of antipsychotics. Its mechanism of action involves blocking muscarinic acetylcholine receptors, which would exacerbate cognitive decline in Alzheimer's disease. In contrast, the other options – Donepezil, Rivastigmine, and Memantine – are cholinesterase inhibitors or NMDA receptor antagonists that aim to improve cholinergic transmission or reduce excitotoxicity in Alzheimer's disease.

**Why Each Wrong Option is Incorrect**
**Option A:** Biperiden's anticholinergic properties would worsen cognitive symptoms in Alzheimer's disease, making it an inappropriate treatment choice.
**Option B:** Donepezil is a reversible cholinesterase inhibitor that increases acetylcholine levels in the brain, thereby improving cognitive function in Alzheimer's patients.
**Option C:** Rivastigmine is a dual-action cholinesterase inhibitor that targets both acetylcholinesterase and butyrylcholinesterase, providing a broader therapeutic effect in Alzheimer's disease.
**Option D:** Memantine is an NMDA receptor antagonist that reduces excitotoxicity caused by excessive glutamate release, providing a complementary mechanism to cholinesterase inhibitors in treating Alzheimer's disease.

**Clinical Pearl / High-Yield Fact**
When treating Alzheimer's disease, it's essential to differentiate between cholinesterase inhibitors (e.g., Donepezil, Rivastigmine) and NMDA receptor antagonists (e.g., Memantine), as they target distinct pathophysiological mechanisms. Anticholinergic medications like Biperiden should be avoided, as they can worsen cognitive symptoms.

**✓ Correct Answer: A. Biperidin**